The Vincent Cristofalo Rising Star Award in Aging Research

Sponsor: American Federation for Aging Research (AFAR)

Award: The award is a framed citation and carries a cash prize of $5,000.

Due Date: February 14, 2025.

The George M. Martin Lifetime Achievement in Mentoring Award

Sponsor: American Federation for Aging Research (AFAR)

Award: The award is a framed citation and carries a cash prize of $5,000.

Due Date: February 14, 2025.

The Terrie Fox Wetle Rising Star Award in Health Services and Aging Research

Sponsor: American Federation for Aging Research (AFAR)

Award: The award is a framed citation and carries a cash prize of $5,000.

Due Date: February 14, 2025.

The Irving S. Wright Award of Distinction

Sponsor: American Federation for Aging Research (AFAR)

Award: The award is a framed citation and carries a cash prize of $5,000.

Due Date: February 14, 2025.

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) (PAR-25-297)

Sponsor: National Institute on Aging

Award: Application budgets are limited to $1,500,000 in direct costs per year and need to reflect the actual needs of the proposed project. For Early Stage projects, the project period is limited to five years. For Late Stage projects, the project period is limited to four years.

Due Date: Multiple due dates; see announcement.

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) (PAR-25-298)

Sponsor: National Institutes of Health

Award: Applicants may request up to $375,000 in direct costs for the entire project period of up to 3 years.

Due Date: Multiple due dates; see announcement.

Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed) (RFA-HG-25-007)

Sponsor: National Institutes of Health

Award: Application budgets are limited to $400,000 direct costs per year. The maximum project period is 3 years.

Due Date: Letter of Intent due February 3, 2025. Application due March 03, 2025.

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) (RFA-TR-25-002)

Sponsor: National Center for Advancing Translational Sciences

Award: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Due Date: June 02, 2025 (Letter of Intent due May 1, 2025) or June 02, 2026 (Letter of Intent due May 1, 2026).

Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed) (RFA-AG-24-049)

Sponsor: National Institute on Aging

Award: Application budgets are capped at $1 million in direct costs per year. The maximum project period is 5 years.

Due Date: Letter of Intent due January 28, 2025. Application due February 28, 2025.

Notice of Intent to Publish a NOFO for Early- and Late-Stage Clinical Trials for the Spectrum of AD/ADRD and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (NOT-AG-24-085)

Sponsor: National Institute on Aging

Due Date: Estimated Publication Date of Notice of Funding Opportunity: December 31, 2024. First Estimated Application Due Date: March 07, 2025.

Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) (PAR-24-330)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) (PAR-25-215)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) (PAR-25-216)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) (PAR-25-272)

Sponsor: National Institutes of Health

Award: Direct costs are limited to $275,000 over the two-year project period. No more than $200,000 in direct costs are allowed in any single year.

Due Date: Multiple due dates; see announcement.

New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) (PAR-25-279)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.